Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Berger

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Pain|April 24, 2004
Clinical characteristics and economic costs of patients with painful neuropathic disordersAriel Berger, Ellen M Dukes, Gerry Oster
Clinical Therapeutics|March 18, 2008
Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemiaAriel Berger, John Edelsberg, Joel Kallich, et al.
Surgical Infections|May 3, 2014
Clinical and economic consequences of post-operative infections following major elective surgery in U.S. hospitalsAriel Berger, John Edelsberg, Holly Yu, et al.
Journal of Medical Economics|April 12, 2013
Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortalityGerry Oster, Ariel Berger, John Edelsberg, et al.
Journal of Occupational and Environmental Medicine|October 22, 2011
Direct and indirect economic costs among private-sector employees with osteoarthritisAriel Berger, Craig Hartrick, John Edelsberg, et al.
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|February 14, 2018
Cost-effectiveness of a Ceramide-Infused Skin Barrier Versus a Standard Barrier: Findings From a Long-Term Cost-effectiveness AnalysisAriel Berger, Gary Inglese, George Skountrianos, et al.
Clinical Therapeutics|December 25, 2003
Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgiaAriel Berger, Ellen Dukes, Bill McCarberg, et al.
Clinical Therapeutics|August 22, 2009
Identification of patients receiving peritoneal dialysis using health insurance claims dataAriel Berger, John Edelsberg, Gary Inglese, et al.
BMC Geriatrics|July 29, 2009
Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorderAriel Berger, Marko Mychaskiw, Ellen Dukes, et al.
The Clinical Journal of Pain|February 23, 2007
Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathyAriel Berger, Ellen Dukes, John Edelsberg, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Pain|April 24, 2004
Clinical characteristics and economic costs of patients with painful neuropathic disordersAriel Berger, Ellen M Dukes, Gerry Oster
Clinical Therapeutics|March 18, 2008
Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemiaAriel Berger, John Edelsberg, Joel Kallich, et al.
Surgical Infections|May 3, 2014
Clinical and economic consequences of post-operative infections following major elective surgery in U.S. hospitalsAriel Berger, John Edelsberg, Holly Yu, et al.
Journal of Medical Economics|April 12, 2013
Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortalityGerry Oster, Ariel Berger, John Edelsberg, et al.
Journal of Occupational and Environmental Medicine|October 22, 2011
Direct and indirect economic costs among private-sector employees with osteoarthritisAriel Berger, Craig Hartrick, John Edelsberg, et al.
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|February 14, 2018
Cost-effectiveness of a Ceramide-Infused Skin Barrier Versus a Standard Barrier: Findings From a Long-Term Cost-effectiveness AnalysisAriel Berger, Gary Inglese, George Skountrianos, et al.
Clinical Therapeutics|December 25, 2003
Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgiaAriel Berger, Ellen Dukes, Bill McCarberg, et al.
Clinical Therapeutics|August 22, 2009
Identification of patients receiving peritoneal dialysis using health insurance claims dataAriel Berger, John Edelsberg, Gary Inglese, et al.
BMC Geriatrics|July 29, 2009
Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorderAriel Berger, Marko Mychaskiw, Ellen Dukes, et al.
The Clinical Journal of Pain|February 23, 2007
Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathyAriel Berger, Ellen Dukes, John Edelsberg, et al.
Pageof 7